Attention is focusing on whether health insurance coverage standards for obesity treatment drugs, which are classified as non-reimbursed drugs that are not covered by health insurance, can be established. The Ministry of Health and Welfare announced that it had started discussions with the Korean Society of Obesity to discuss the necessity of reimbursement for obesity treatment and treatment and a reimbursement model to solve the problem of the domestic obesity rate. However, specific details, such as when and which obesity treatment and treatment will be applied, have yet to be confirmed.

On the 14th, the Ministry of Health and Welfare submitted such a plan to the National Assembly regarding the reimbu